[Shiga toxin production by Escherichia coli strains and antibiotics].
Sidorenko
S V
SV
D000900:Anti-Bacterial Agents / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D004926:Escherichia coli / Q000235:genetics / Q000378:metabolism* / Q000472:pathogenicity; D004927:Escherichia coli Infections / Q000150:complications / Q000188:drug therapy*; D019453:Escherichia coli O157 / Q000235:genetics / Q000378:metabolism / Q000472:pathogenicity; D006463:Hemolytic-Uremic Syndrome / Q000209:etiology*; D006801:Humans; D022603:Shiga Toxins / Q000096:biosynthesis*
D000900:Anti-Bacterial Agents; D022603:Shiga Toxins